Quanterix Corp (QTRX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $134.84M
Last updated: Nov 17, 2026 at 4:15 PM ET
Quanterix Corp (QTRX) Statistics
Quanterix (QTRX) has a market cap of $134.84M and an enterprise value of $98.97M. It kept -75.05% of revenue as net income over the last 12 months. It holds $35.86M more cash than debt, 26.60% of its market cap.
Total Valuation
Enterprise value is 26.60% below the market cap, as cash exceeds debt.
| Market Cap | $134.84M |
|---|---|
| Enterprise Value | $98.97M |
| Latest price (Nov 17, 2026) | $2.86 |
Key Dates
The next earnings report is expected on Jan 6, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 6, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.9x and 0.6x. Its year-end P/S ranged from 2.0x to 17.3x from 2017 to 2025.
| P/S Ratio | 0.9x |
|---|---|
| Forward P/S | 0.9x |
| P/B Ratio | 0.6x |
| P/TBV Ratio | 1.2x |
Price Statistics
The stock is down 50.17% over 52 weeks and trades 6.23% below its 50-day average.
| Beta (1Y) | 2.10 |
|---|---|
| 52-Week Change | -50.17% |
| 1-Month Change | +3.25% |
| 3-Month Change | -3.38% |
| 6-Month Change | +13.94% |
| 5-Year Change | -94.26% |
| Total Return (1Y) | -50.17% |
| Total Return (3Y CAGR) | -49.67% |
| Total Return (5Y CAGR) | -42.74% |
| Return vs SPY (1Y) | -60.67% |
| Max Drawdown (1Y) | -69.98% |
| Max Drawdown (3Y) | -91.56% |
| Sharpe Ratio (1Y) | -0.69 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $3.05 |
| 200-Day Average | $3.63 |
| 52-Week Range | $2.15 to $8.77 |
| RSI (14 Days) | 46.2 |
| Average Volume (20 Days) | 501.15K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.09x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.09x |
|---|---|
| Quick Ratio | 2.22x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -50.69% over the last 12 months, against a 5-year average of -19.29%.
| Return on Equity (ROE) | -50.69% |
|---|---|
| Return on Assets (ROA) | -37.01% |
| ROE (5Y Average) | -19.29% |
| ROA (5Y Average) | -15.14% |
| ROIC (5Y Average) | -39.00% |
| Asset Turnover | 0.40x |
| Inventory Turnover | 1.87x |
| Receivables Turnover | 5.98x |
| Cash Conversion Cycle | 211 days |
Scores
QTRX has an Altman Z-Score of -2.43, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -2.43 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $148.15M over the last 12 months is up 13.78% from the 12 months before.
| Revenue | $148.15M |
|---|---|
| Revenue Growth (YoY) | +13.78% |
| Gross Profit | $61.78M |
| Operating Income | -$138.04M |
| Pretax Income | -$110.61M |
| Net Income | -$111.18M |
| EBITDA | -$86.65M |
| Reported EPS (TTM) | -$1.22 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 73.01% of the $300.44M in total assets.
| Cash and Equivalents | $35.86M |
|---|---|
| Total Debt | $0 |
| Net Cash | $35.86M |
| Net Cash Per Share | $0.76 |
| Working Capital | $106.98M |
| Shareholder Equity | $219.35M |
| Book Value Per Share | $4.63 |
| Tangible Book Value | $116.94M |
| Tangible Book Per Share | $2.47 |
| Total Assets | $300.44M |
| Total Liabilities | $81.09M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $356.00K of capital spending, operating cash flow left -$56.23M of free cash flow.
| Operating Cash Flow | -$55.87M |
|---|---|
| Capital Expenditures | $356.00K |
| Free Cash Flow | -$56.23M |
| FCF Per Share | -$1.19 |
| Depreciation and Amortization | $27.30M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -93.18%, against a 5-year average of -63.24%.
| Gross Margin | 41.70% |
|---|---|
| Operating Margin | -93.18% |
| Pretax Margin | -74.66% |
| Net Margin | -75.05% |
| EBITDA Margin | -58.49% |
| FCF Margin | -37.95% |
| Gross Margin (5Y Average) | 53.89% |
| Operating Margin (5Y Average) | -63.24% |
| Net Margin (5Y Average) | -54.59% |
Growth
Revenue grew 9.59% a year over 3 years.
| Revenue Growth (3Y CAGR) | +9.59% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.97% |
| Book Value Per Share Growth (2Y CAGR) | -17.27% |
| Tangible Book Per Share Growth (2Y CAGR) | -43.08% |
Dividends and Yields
QTRX does not pay a dividend. Its free cash flow yield is -41.49%.
| FCF Yield | -41.49% |
|---|---|
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
Peer Position
Against 11 similar companies, QTRX has the 9th highest P/S.
P/S RatioPeer median 2.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.87%
| P/S Ratio | 0.9x vs 2.6x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +13.78% vs +7.87% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.08% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.08% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About QTRX
What is QTRX's market cap?
Quanterix has a market cap of $134.84M. Its enterprise value, which adds debt and subtracts cash, is $98.97M.
How many shares of QTRX are outstanding?
Quanterix has 47.39M shares outstanding. The count is up 2.88% from a year earlier.
Does QTRX pay a dividend?
No. Quanterix does not pay a dividend.
How much debt does QTRX have?
Quanterix has $0 of total debt and $35.86M of cash and equivalents, a net cash position of $35.86M.
QTRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts